Asia
In Asia, Naproxen Sodium prices fluctuated during 2025 but stayed mostly steady. At the start of the year, some countries faced problems with medicine supply, slow payments, and strict pricing rules. These issues made it harder for manufacturers to keep production smooth, which caused small cost increases for APIs like Naproxen Sodium. But later in the year, supply improved as more local API production came online and shipping delays became less common. Because of this, prices slowly settled. Overall, the Asian market showed mild pressure at first and then became calmer with slightly softer prices toward the end of the year.
Europe
In Europe, prices for Naproxen Sodium stayed fairly stable throughout 2025. Strong rules, organized purchasing systems, and steady production kept the market balanced. Competition between suppliers also helped prevent big price increases. The UK-US medicines agreement boosted confidence in the wider European region, supporting investment and keeping supply chains strong. Demand stayed normal, and most buyers already had enough stock, so prices drifted slightly lower in the second half of the year. The overall trend in Europe was stable supply and small price dips.
North America
In North America, prices changed more than in other regions. Early in the year, there was concern that new U.S. tariffs or policy changes could make imported drug ingredients more expensive. Since most APIs are still made overseas, this created some uncertainty and kept prices a bit firm for a while. Later in the year, the U.S. government’s new order to lower drug prices put pressure on suppliers to reduce costs where possible. Buyers also waited for clearer rules, which slowed demand and led to small price drops toward year-end. The market ended 2025 with softer prices and more cautious purchasing.